HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jay Chhablani Selected Research

coomassie Brilliant Blue

1/2022Brilliant Blue G toxicity in macular hole surgeries: A report on combined phototoxicity and dye-induced macular damage.
4/2017Inner retinal thinning after Brilliant Blue G-assisted internal limiting membrane peeling for vitreoretinal interface disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jay Chhablani Research Topics

Disease

43Macular Degeneration (Age-Related Maculopathy)
12/2022 - 09/2008
29Macular Edema
03/2022 - 05/2013
28Central Serous Chorioretinopathy
10/2022 - 01/2014
18Diabetic Retinopathy (Retinopathy, Diabetic)
09/2022 - 05/2013
18Retinal Detachment (Retinal Detachments)
07/2021 - 05/2012
15Choroidal Neovascularization
03/2021 - 09/2008
12Retinal Vein Occlusion
03/2022 - 05/2010
10Polypoidal Choroidal Vasculopathy
10/2021 - 09/2010
9Retinal Diseases
12/2022 - 04/2014
9Atrophy
03/2022 - 12/2019
8Telangiectasis (Telangiectasia)
05/2022 - 11/2012
8Endophthalmitis (Ophthalmia)
05/2018 - 01/2014
6Epiretinal Membrane (Epiretinal Membranes)
10/2022 - 04/2012
6Retinal Artery Occlusion
07/2022 - 10/2018
6Ganglion Cysts (Ganglion)
01/2018 - 02/2015
5Glaucoma
03/2022 - 01/2018
5Retinal Perforations
01/2022 - 12/2015
5Inflammation (Inflammations)
01/2018 - 07/2010
4Hemorrhage
12/2022 - 07/2018
4Uveitis
01/2022 - 01/2016
4Neoplasms (Cancer)
01/2022 - 12/2010
4Cataract (Cataracts)
09/2020 - 12/2016
4Vitreous Hemorrhage
01/2020 - 05/2015
4Toxic Optic Neuropathy
02/2017 - 02/2013
3Geographic Atrophy
05/2022 - 05/2015
3Retinitis Pigmentosa (Pigmentary Retinopathy)
03/2022 - 01/2016
3Choroid Diseases
01/2021 - 12/2012
3Microaneurysm
04/2020 - 05/2012
3Hemangioma (Angioma)
12/2019 - 01/2008
3Cicatrix (Scar)
12/2019 - 06/2013
3Burns
07/2018 - 05/2014
3Pain (Aches)
10/2017 - 05/2014
2Wounds and Injuries (Trauma)
10/2022 - 08/2014
2Vitreous Detachment (Posterior Vitreous Detachment)
10/2022 - 01/2018
2Blindness (Hysterical Blindness)
05/2022 - 07/2020
2Ischemia
03/2022 - 07/2014
2Choroideremia
12/2021 - 02/2021
2Hamartoma
12/2021 - 01/2019
2Polyps
04/2021 - 09/2020
2Fibrosis (Cirrhosis)
12/2019 - 10/2019
2Ocular Hypertension (Glaucoma, Suspect)
06/2019 - 12/2018
2Retinal Arterial Macroaneurysm
06/2019 - 01/2018
2Retinopathy of Prematurity (Retrolental Fibroplasia)
01/2019 - 07/2014
2Vitelliform Macular Dystrophy
01/2018 - 07/2012
2Coloboma (Colobomas)
10/2017 - 09/2016
2White Dot Syndromes
12/2016 - 03/2015
2Edema (Dropsy)
01/2016 - 03/2015
2Idiopathic Juxtafoveal Retinal Telangiectasia
11/2014 - 04/2014
1Chorioretinitis
10/2022
1Melanoma (Melanoma, Malignant)
10/2022
1Retinal Neoplasms
04/2022
1Vascular Diseases (Vascular Disease)
04/2022
1Erectile Dysfunction
03/2022
1Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy)
03/2022

Drug/Important Bio-Agent (IBA)

65Retinaldehyde (Retinal)IBA
07/2022 - 04/2012
25Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2022 - 11/2012
25afliberceptIBA
04/2021 - 05/2015
19Bevacizumab (Avastin)FDA Link
03/2022 - 07/2012
17Fluorescein (Funduscein)FDA LinkGeneric
09/2022 - 05/2012
11Ranibizumab (Lucentis)FDA Link
04/2022 - 09/2008
11Dexamethasone (Maxidex)FDA LinkGeneric
01/2021 - 01/2016
91-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2021 - 12/2015
8Silicone OilsIBA
07/2021 - 05/2012
7Indocyanine Green (Cardio-Green)FDA LinkGeneric
07/2022 - 12/2016
7SteroidsIBA
09/2020 - 07/2014
7Anti-Bacterial Agents (Antibiotics)IBA
05/2018 - 01/2014
6Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2018
5Pharmaceutical PreparationsIBA
03/2022 - 06/2013
5perflutren (octafluoropropane)FDA Link
01/2019 - 01/2016
5Endothelial Growth FactorsIBA
01/2018 - 12/2015
3Retinal Pigments (Pigments, Visual)IBA
04/2022 - 07/2013
3Coloring Agents (Dyes)IBA
01/2022 - 02/2015
3Eplerenone (Inspra)FDA LinkGeneric
11/2021 - 01/2018
3Verteporfin (Visudyne)FDA Link
01/2019 - 04/2017
2Sildenafil Citrate (Viagra)FDA Link
03/2022 - 01/2018
2coomassie Brilliant BlueIBA
01/2022 - 04/2017
2TamoxifenFDA LinkGeneric
01/2022 - 01/2018
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2018 - 01/2016
2N-acetyltryptophanamide (NATA)IBA
01/2016 - 01/2016
2Angiogenesis InhibitorsIBA
12/2015 - 10/2014
1Immunoglobulin G (IgG)IBA
10/2022
1Phosphodiesterase 5 InhibitorsIBA
03/2022

Therapy/Procedure

28Therapeutics
12/2022 - 11/2012
28Lasers (Laser)
09/2022 - 05/2013
18Injections
04/2022 - 01/2016
17Vitrectomy
01/2022 - 04/2012
14Light Coagulation
01/2022 - 05/2013
14Photochemotherapy (Photodynamic Therapy)
11/2021 - 09/2008
7Intravitreal Injections
11/2021 - 10/2014
6Traction
10/2022 - 05/2014
3Brachytherapy
12/2022 - 12/2010
3Scleral Buckling
09/2020 - 12/2013
2Laser Therapy (Surgery, Laser)
12/2022 - 10/2021
2Drug Therapy (Chemotherapy)
01/2022 - 01/2016
2Vitreoretinal Surgery
07/2021 - 05/2015
2Induced Hyperthermia (Thermotherapy)
12/2019 - 01/2008
2Off-Label Use
02/2017 - 12/2016
2Aftercare (After-Treatment)
01/2017 - 06/2013
2Contact Lenses
10/2015 - 02/2015
2Bandages (Bandage)
10/2015 - 02/2015